Natriuretic Peptide Receptor-1 Agonist for Resistant Hypertension A Randomized Phase 2 Trial

Journal:

Journal of the American College of Cardiology

Published:

2026-01-22

DOI:

10.1016/j.jacc.2025.11.045

Affiliations:

7

Authors:

10

Go to article

Institutions	Authors	Share
Novartis Pharmaceuticals Corporation, United States of America (USA)	4.000000	0.40
UCL, United Kingdom (UK)	1.000000	0.10
Hospital of the University of Pennsylvania, Penn, United States of America (USA)	1.000000	0.10
University of Connecticut (UConn), United States of America (USA)	1.000000	0.10
Tulane University, United States of America (USA)	1.000000	0.10
Novartis, Switzerland	1.000000	0.10
Centre d'Investigation Clinique - Epidémiologie Clinique (CIC-EC 1418), France	1.000000	0.10

Interested in Cardiovascular Medicine and Haematology?